Pharm.D. Students
Doctor of Pharmacy
Incoming Student Characteristics
The Pharm.D. is a professional degree for pharmacists similar to the M.D. for physicians or D.D.S. for dentists. Typical applicants have solid grades in their science and math prerequisite courses (letter grade of C minus or better). Applicants typically have a bachelor’s degree, but it is not required to enter the PharmD program. Students are subject to the prerequisite requirements in place when they are admitted to the program.
All PharmD candidates that apply to the Eshelman School of Pharmacy must apply in PharmCAS. Application data from each incoming class year is analyzed to improve overall decision making related to class composition. Through analysis of these data, the School can better target recruitment strategies to improve the admissions outcomes of our students and the School.
as of Mar. 14, 2023
| Incoming Class Year | Completed Applications (1) | North Carolina Applications (2) | North Carolina Rural County Applications (3) | UNC Chapel Hill Applicants (5) | Overall Program Acceptance Rate (4) |
|---|---|---|---|---|---|
| 2022 | 570 (+6%) | 124 (22%) | 30 (.5%) | 28 (.5%) | 286 (50%) |
| 2021 | 540 (+19%) | 129 (24%) | 22 (.4%) | 32 (.6%) | 238 (44%) |
| 2020 | 454 (-19%) | 114 (25%) | 27 (.6%) | 26 (.6%) | 187 (42%) |
| 2019 | 560 (+ 14%) | 115 (21%) | 29 (.5%) | 25 (.4%) | 216 (39%) |
| 2018 | 492 (-13%) | 140 (28%) | 40 (.8%) | 32 (.7%) | 206 (42%) |
| 2017 | 567 (+ .7%) | 182 (32%) | 35 (.6%) | 42 (.7%) | 224 (40%) |
| 2016 | 563 (-12%) | 185 (33%) | 40 (.7%) | 41 (.7%) | 213 (38%) |
| 2015 | 641 | 211 (33%) | 35 (.5%) | 57 (.8%) | 229 (36%) |
(1) Completed applications include all Local Status types, but excludes Unverified.
(2) NC Applications is all completed applications with a self-reported permanent home residence state of North Carolina.
(3) NC Rural County Applications is all completed applications with a self-reported permanent home residence city that maps to a rural county designation as reported here by the NC Rural Center: https://www.ncruralcenter.org/about-us/
(4) Program Acceptance Rate is all completed applications with a final Local Status of: Declined Asheville – Deposit Paid, Declined Asheville – No Pay, Declined Offer CH – Deposit Paid, Declined Offer CH – No Deposit, Declined CH- No Deposit, Deferred, Matriculated – AVL, Matriculated – CH, Matriculated-Asheville, Matriculated-Chapel Hill, Rescinded Offer, Withdraw – Administrative – Did not respond to offer, Withdraw – After Matriculation. This total application pool in this final status is then divided into the pool of total completed applications in that admission cycle to derive the acceptance rate.
(5) UNC Chapel Hill Feeder School Applicants is all completed applications that have listed UNC Chapel Hill in either Previous College 0 or Previous college 1 field in their application.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
The following table outlines a select set of student characteristics for each incoming class. Through analysis of these data, the School can assess and monitor key student characteristics and pre-enrollment performance trends to ensure that the PharmD program is optimized to deliver on its intended outcomes relative to the School’s strategic plan.
| Incoming Year | # of Enrolled Students (1) | Average Incoming GPA (2) | Average PCAT (3) | Average Age of Applicant (4) |
|---|---|---|---|---|
| 2022 | 137 | 3.57 | 87.44 | 21.8 |
| 2021 | 147 | 3.54 | 87.78* | 21.9 |
| 2020 | 123 | 3.57 | 88.10 | 21.6 |
| 2019 | 160 | 3.57 | 89.61 | 21.7 |
| 2018 | 145 | 3.51 | 87.11 | 21.8 |
| 2017 | 154 | N/A | 86.84 | 21.5 |
| 2016 | 141 | N/A | 87.94 | 22.0 |
| 2015 | 154 | N/A | 88.01 | 21.6 |
(1) # of Enrolled Students = Count of unique student IDs that were enrolled at the completion of the Fall academic term and reported in the Incoming Student Headcount Report. Snapshot data for 2015 to 2018 is not available for validation at this time.
(2) Average Incoming GPA = Average GPA of all applicants in PharmCAS that were in a status of Matriculated at the time of cycle close and as reported in the PharmD Admission Cycle Report.
(3) Average PCAT Composite = The composite score is calculated from the Biology, Chemistry and Reading sections as reported in the PharmCAS application. This is averaged for all students in the Matriculated status at the time of cycle close and is reported in the PharmD Admissions Cycle Report. PCAT transitioned to an optional admissions requirement in 2021.
(4) Average Age of Applicant = The age at the time of PharmCAS application is self-reported. This is averaged for all students in the Matriculated status at the time of cycle close and is reported in the PharmD Admissions Cycle Report.
* 2021 was the first year that the PCAT score submission was optional for admissions.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
The following table outlines the gender and residency mix for each incoming class. Through analysis of these data, the School can assess and monitor these metrics to ensure that the PharmD program is optimized to deliver on its intended outcomes relative to the School’s strategic plan.
| Incoming Year | Female (%) | Male (%) | North Carolina Residents (%) | Non-NC Residents (%) |
|---|---|---|---|---|
| 2022 | 74 | 26 | 45 | 55 |
| 2021 | 73 | 27 | 39 | 61 |
| 2020 | 71 | 29 | 52 | 48 |
| 2019 | 78 | 22 | 42 | 58 |
| 2018 | 67 | 33 | 43 | 57 |
| 2017 | 68 | 32 | 59 | 41 |
| 2016 | 70 | 30 | 51 | 49 |
| 2015 | 68 | 32 | 60 | 40 |
| 2014 | 65 | 35 | 62 | 38 |
| 2013 | 61 | 39 | 64 | 36 |
| 2012 | 67 | 33 | 72 | 28 |
| 2011 | 68 | 31 | 78 | 22 |
| 2010 | 62 | 35 | 77 | 23 |
| 2009 | 70 | 30 | 72 | 28 |
| 2008 | 65 | 35 | 86 | 14 |
| 2007 | 70 | 30 | 84 | 16 |
(1) Female (%) = Count of unique student IDs that self-identified as Female during their incoming class year Fall Term snapshot as reported in the Incoming Student Headcount Report.
(2) Male (%) = Count of unique student IDs that self-identified as Male during their incoming class year Fall Term snapshot as reported in the Incoming Student Headcount Report.
(3) North Carolina Residents (%) = Count of unique student IDs that self-identified as having a permanent residence of North Carolina during their incoming Fall Term class year snapshot as reported in the Incoming Student Headcount Report.
(4) Non-North Carolina Residents (%) = Count of unique student IDs that self-identified as having a permanent residence outside of North Carolina during their incoming Fall Term class year snapshot as reported in the Incoming Student Headcount Report.
Authoritative Data Source – Report Catalog
- Incoming Student Headcount Report (1)(2)(3)(4)
as of Mar. 10, 2023
The following table outlines the race and ethnicity mix for each incoming class. Through analysis of these data, the School can assess and monitor these metrics to ensure that the PharmD program is optimized to deliver on its intended outcomes relative to the School’s strategic plan.
| Incoming Year | White (%) | Asian (%) | African American or Black (%) | Hispanic* (%) | Native American or Alaska Native (%) | Two or more races* (%) | Unknown/ Other (%) |
|---|---|---|---|---|---|---|---|
| 2022 | 51 | 18 | 11 | 9 | 0 | 7 | 4 |
| 2021 | 50 | 24 | 7 | 6 | 1 | 6 | 6 |
| 2020 | 55 | 22 | 4 | 7 | 0 | 7 | 5 |
| 2019 | 60 | 19 | 8 | 8 | <1 | <1 | 5 |
Race / Ethnicity (%) = The count of unique student IDs that self-identified as that specific race/ethnicity during their incoming Fall Term class year snapshot. The non-resident alien designation in Connect Carolina is categorized in the Unknown/Other category.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
The following table outlines the total student enrollment (4-year program), campus of the student and dual degree designation as of the end of each academic year. Through analysis of these data, the School can assess and monitor enrollment trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Year | Total # of Enrolled Students (1) | Chapel Hill Campus | Asheville Campus* | Dual Degree - MBA (2) | Dual Degree - MPH (2) |
|---|---|---|---|---|---|
| 2022 | 568 | 517 | 60 | 20 | 5 |
| 2021 | 578 | 511 | 78 | 21 | 10 |
| 2020 | 606 | 518 | 88 | 11 | 13 |
| 2019 | 580 | 491 | 89 | 8 | 6 |
(1) Total # of Enrolled Students = Total count of unique student IDs (PY1, PY2, PY3 or PY4) that were enrolled as either full-time or part-time students by campus designation in the PharmD program in the Fall, Spring or Summer I or II academic terms.
(2) Dual Degree = Total count of unique student IDs (PY1, PY2, PY3 or PY4) that were enrolled as either full-time or part-time students in the dual PharmD / MBA (Kenan-Flagler Business School) and PharmD / MPH (Gillings School of Global Public Health) program in the Fall, Spring or Summer I or II academic terms. Note – The dual-degree program counts by year are provided by the Office of Student Affairs annually (OSA) and are not available for reporting out of Connect Carolina.
*The Asheville campus opened in 2011.
Authoritative Data Source – Report Catalog
Learning Assessment Framework
as of Mar. 10, 2023
Frequent assignments and formal assessment (quizzes or exams) are an essential part of ensuring students are on track with the desired competency and skill acquisition. Course Directors maintain a comprehensive syllabus each academic term that identify “high stakes” assignments and assessments that represent a substantial component of the course grade. Through analysis of these assignments and assessments by category and date of occurrence, School leadership can effectively manage the student assignment and assessment burden across the curriculum by academic term.
| Academic Term | Clinical Simulation (1) | Exams (2) | Total | Unique Courses Reporting | Assessments per Course Ratio |
|---|---|---|---|---|---|
| Fall 2023 | TBD | TBD | TBD | TBD | TBD |
| Spring 2023 | 24 | 42 | 66 | 9 | 7.3 |
| Fall 2022 | 16 | 41 | 57 | 11 | 5.2 |
| Spring 2022 | 25 | 30 | 55 | 8 | 6.9 |
| Fall 2021 | 16 | 38 | 54 | 9 | 6.0 |
| Spring 2021 | 31 | 32 | 63 | 8 | 7.9 |
(1) Clinical Simulation is a category used to identify skills assessments (eg, OSCE) administered using the CAE LearningSpace. (https://www.caehealthcare.com/learningspace/enterprise/)
(2) Exams is a category used to identify knowledge assessments administered using ExamSoft. (https://examsoft.com/)
Authoritative Data Source – Report Catalog
Student Outcomes
last updated on Mar. 10, 2023
On time graduation is an important success factor of the PharmD program and is a measure that is closely monitored. Through analysis of these data, the School can assess and monitor on-time graduation performance trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Graduating Year | Four-Year Graduation Rate (%) | Delayed (%)* | Dismissed (%) | Withdrew (%) |
|---|---|---|---|---|
| 2022 | 93 | <8 | 0 | <1 |
| 2021 | 97 | 3 | 0 | <1 |
| 2020 | 94 | <4 | <1 | <1 |
| 2019 | 90 | 8 | 0 | 2 |
| 2018 | 96 | 2 | 0 | 2 |
| 2017 | 97 | 3 | <1 | 0 |
| 2016 | 96 | 2 | 0 | 2 |
| 2015 | 93 | 4 | 0 | 2 |
| 2014 | 92 | 5 | 3 | 1 |
| 2013 | 95 | 3 | <1 | <1 |
| 2012 | 92 | 3 | <1 | 4 |
| 2011 | 90 | 5 | 4 | <1 |
| 2010 | 95 | 2 | 0 | 3 |
| 2009 | 94 | 3 | 1 | 2 |
| 2008 | 97 | 2 | <1 | <1 |
2022: 11 students were delayed: 5 to meet the requirements for the PharmD/MBA dual degree program, 2 to meet the requirements for the PharmD/MPH dual degree program, 2 for leave of absence, 1 for medical leave, and 1 other
2021: 5 students were delayed: 2 to meet the requirements for the PharmD/MBA dual degree program, 2 for academic reasons, and 1 medical leave
2020: 6 students were delayed: 4 to meet the requirements for the PharrmD/MPH dual degree program, 1 to meet the requirements for the PharrmD/MBA dual degree program, 1 for medical reasons
2019: 13 students were delayed: 3 to meet the requirements for the PharrmD/MPH dual degree program, 1 to meet the requirements for the PharrmD/MBA dual degree program, 2 for academic reasons, 3 for medical reasons, 3 for leave of absence, and 1 other
2018: 4 students were delayed: 3 for medical reasons and 1 to meet the requirements of the PharmD/MPH dual degree program
2017: 8 students were delayed: 3 for academic reasons, 1 for medical reasons, 3 to meet the requirements of the PharmD/MPH dual degree program, and 1 to meet the requirements of the PharmD/MBA dual degree program
2016: 4 students were delayed: 1 for academic reasons, 2 for medical reasons, and 1 for other reason
2015: 7 students were delayed: 4 for academic reasons, 1 for medical reasons, and 2 for other reasons
2014: 7 students were delayed: 2 for academic reasons, 4 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2013: 5 students were delayed: 3 for academic reasons, 1 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2012: 5 students were delayed: 1 for academic reasons, 3 for medical reasons, and 1 to meet the requirements of the PharmD/MBA dual degree program
2011: 7 students were delayed: 5 for medical reasons, 2 for other reasons
2010: 4 students were delayed: 1 for academic reasons, 2 for medical reasons, and 1 for other reasons
2009: 4 students were delayed: 3 for academic reasons, 1 for other reason
2008: 2 students were delayed: 1 for academic reasons, 1 for medical reasons
as of Mar. 10, 2023
The NAPLEX and the MPJE exams are critical outcome measures that help School leadership assess relative competency performance against benchmarks. Through analysis of these data, the School can assess and monitor performance trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Graduating Year | NAPLEX First-Time (%) | National Benchmark | Performance vs. National | MPJE In-state First-Time (%) | National Benchmark | Performance vs. National |
|---|---|---|---|---|---|---|
| 2022 | 94 | 80 | 17% Higher | 94 | 77 | 22% Higher |
| 2021* | 97 | 82 | 17% Higher | 89 | 79 | 13% Higher |
| 2020 | 98 | 86 | 14% Higher | 95 | 83 | 15% Higher |
| 2019 | 92 | 87 | 12% Higher | 92 | 83 | 9% Higher |
| 2018 | 95 | 89 | 7% Higher | 93 | 84 | 9% Higher |
| 2017 | 92 | 88 | 5% Higher | 90 | N/A | N/A |
| 2016 | 95 | 86 | 10% Higher | 95 | N/A | N/A |
* Revised NAPLEX blueprint occurred in 2021 – click here for details of the change.
as of Mar. 10, 2023
Students’ acceptance of a position at or around graduation is a critical success factor of the PharmD program that is closely monitored. Through analysis of these data, the School can assess and monitor placement trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Class Year | Employment (1) | Residency (2) | Fellowship (3) | Other (4) | Students Graduated | Position Acceptance Rate | First or Second Choice Acceptance Rate |
|---|---|---|---|---|---|---|---|
| 2022 | 29 | 80 | 14 | 1 | 135 | 124 / 135 = 92% | 103 / 124 = 83% |
(1) Employment is defined as accepting a position in Community Pharmacy (chain), Community Pharmacy (independent), Nuclear, Life Sciences Consulting, Long Term Care, Consulting or Other.
(2) Residency is defined as accepting a post graduate residency training position in any of the following specialties. Acute Care, Ambulatory Care, Community, Hospital/Health System Admin, Managed Care or Other.
(3) Fellowship is defined as accepting a post graduate fellowship training position in any of the following specialties. Medical Affairs/Medical Information/Medical Communications, Clinical Research/Drug Development, Regulatory Affairs, Managed Care, Health Economics & Outcomes Research/Market Access, Drug Information, Commercial, Clinical Pharmacology/Pharmacokinetics/Pharmacodynamics/Pharmacometrics.
(4) Other is defined as any position accepted that is not categorized as employment, residency or fellowship. In some cases, this might be enrollment in postgraduate education.
2022 data collected via the Graduating Student Survey that closed on 5/2022. This was supplemented with student follow-up through November.
2021 data collected via the Graduating Student Survey that closed on 5/2021. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2020 data collected via the Graduating Student Survey that closed on 5/2020. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2019 data collected via the Graduating Student Survey that closed on 5/2019. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
Students’ acceptance of a position at or around graduation is a critical success factor of the PharmD program that is closely monitored. Through analysis of these data, the School can assess and monitor placement trends to deliver on its intended outcomes relative to the School’s strategic plan.
Employment position location
| Class Year | North Carolina | Outside North Carolina | Total |
|---|---|---|---|
| 2022 | 13 (57%) | 10 (43%) | 23 |
Residency position location
| Class Year | North Carolina | Outside North Carolina | Total |
|---|---|---|---|
| 2022 | 26 (33%) | 53 (67%) | 79 |
Fellowship position
| Class Year | North Carolina | Outside North Carolina | Total |
|---|---|---|---|
| 2022 | 5 (36%) | 9 (64%) | 14 |
2022 data collected via the Graduating Student Survey that closed on 5/04/2022. This was supplemented with student follow-up through November.
2021 data collected via the Graduating Student Survey that closed on 5/2021. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2020 data collected via the Graduating Student Survey that closed on 5/2020. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2019 data collected via the Graduating Student Survey that closed on 5/2019. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
Students’ acceptance of a position at or around graduation is a critical success factor of the PharmD program that is closely monitored. Through analysis of these data, the School can assess and monitor placement trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Class Year | Total | First choice | Second choice | Other choice | First or Second choice |
|---|---|---|---|---|---|
| 2022 | 29 | 18 (62%) | 3 (10%) | 8 (28%) | 21 (72%) |
2022 data collected via the Graduating Student Survey that closed on 5/04/2022. This was supplemented with student follow-up through November.
2021 data collected via the Graduating Student Survey that closed on 5/2021. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2020 data collected via the Graduating Student Survey that closed on 5/2020. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2019 data collected via the Graduating Student Survey that closed on 5/2019. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
Students’ acceptance of a position at or around graduation is a critical success factor of the PharmD program that is closely monitored. Through analysis of these data, the School can assess and monitor placement trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Class Year | Total | First choice | Second choice | Other choice | First or Second choice |
|---|---|---|---|---|---|
| 2022 | 80 | 53 (66%) | 16 (20%) | 11 (14%) | 69 (86%) |
2022 data collected via the Graduating Student Survey that closed on 5/04/2022. This was supplemented with student follow-up that through November.
2021 data collected via the Graduating Student Survey that closed on 5/2021. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2020 data collected via the Graduating Student Survey that closed on 5/2020. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2019 data collected via the Graduating Student Survey that closed on 5/2019. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
Authoritative Data Source – Report Catalog
as of Mar. 10, 2023
Students’ acceptance of a position at or around graduation is a critical success factor of the PharmD program that is closely monitored. Through analysis of these data, the School can assess and monitor placement trends to deliver on its intended outcomes relative to the School’s strategic plan.
| Class Year | Total | First choice | Second choice | Other choice | First or Second choice |
|---|---|---|---|---|---|
| 2022 | 14 | 9 (64%) | 4 (29%) | 1 (7%) | 13 (93%) |
2022 data collected via the Graduating Student Survey that closed on 5/04/2022. This was supplemented with student follow-up through November.
2021 data collected via the Graduating Student Survey that closed on 5/2021. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2020 data collected via the Graduating Student Survey that closed on 5/2020. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
2019 data collected via the Graduating Student Survey that closed on 5/2019. This was supplemented with student follow-up that ended in November. Please click HERE to view the summary results.
Authoritative Data Source – Report Catalog